| pubmed-article:20032772 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20032772 | lifeskim:mentions | umls-concept:C0031117 | lld:lifeskim |
| pubmed-article:20032772 | lifeskim:mentions | umls-concept:C0085584 | lld:lifeskim |
| pubmed-article:20032772 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:20032772 | lifeskim:mentions | umls-concept:C0041984 | lld:lifeskim |
| pubmed-article:20032772 | lifeskim:mentions | umls-concept:C1515075 | lld:lifeskim |
| pubmed-article:20032772 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:20032772 | lifeskim:mentions | umls-concept:C1579410 | lld:lifeskim |
| pubmed-article:20032772 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:20032772 | pubmed:dateCreated | 2010-1-20 | lld:pubmed |
| pubmed-article:20032772 | pubmed:abstractText | Peripheral neuropathy and central nervous system neurodegeneration may result from the mitochondrial toxicity of some antiretroviral nucleoside analogues. We investigated whether this neuropathology may be antagonized by uridine supplementation in vivo. | lld:pubmed |
| pubmed-article:20032772 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20032772 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20032772 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20032772 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20032772 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20032772 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20032772 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20032772 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20032772 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20032772 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:20032772 | pubmed:issn | 1473-5571 | lld:pubmed |
| pubmed-article:20032772 | pubmed:author | pubmed-author:MüllerKlausK | lld:pubmed |
| pubmed-article:20032772 | pubmed:author | pubmed-author:WalkerUlrich... | lld:pubmed |
| pubmed-article:20032772 | pubmed:author | pubmed-author:VenhoffNilsN | lld:pubmed |
| pubmed-article:20032772 | pubmed:author | pubmed-author:BonnetJacques... | lld:pubmed |
| pubmed-article:20032772 | pubmed:author | pubmed-author:LebrechtDirkD | lld:pubmed |
| pubmed-article:20032772 | pubmed:author | pubmed-author:BeauvoitBertr... | lld:pubmed |
| pubmed-article:20032772 | pubmed:author | pubmed-author:KirschnerJanb... | lld:pubmed |
| pubmed-article:20032772 | pubmed:author | pubmed-author:DeveaudCather... | lld:pubmed |
| pubmed-article:20032772 | pubmed:author | pubmed-author:VenhoffAna... | lld:pubmed |
| pubmed-article:20032772 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20032772 | pubmed:day | 28 | lld:pubmed |
| pubmed-article:20032772 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:20032772 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20032772 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20032772 | pubmed:pagination | 345-52 | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:meshHeading | pubmed-meshheading:20032772... | lld:pubmed |
| pubmed-article:20032772 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20032772 | pubmed:articleTitle | Oral uridine supplementation antagonizes the peripheral neuropathy and encephalopathy induced by antiretroviral nucleoside analogues. | lld:pubmed |
| pubmed-article:20032772 | pubmed:affiliation | Department of Rheumatology and Clinical Immunology, Medizinische Universitätsklinik, Freiburg, Germany. | lld:pubmed |
| pubmed-article:20032772 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20032772 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
